Short-term synaptic plasticity.

Short-term synaptic plasticity.

by

Synaptic transmission is a dynamic course of. Postsynaptic responses wax and wane as presynaptic exercise evolves. This distinguished attribute of chemical synaptic transmission is an important determinant of the response properties of synapses and, in flip, of the stimulus properties chosen by neural networks and of the patterns of exercise generated by these networks. This evaluation focuses on synaptic modifications that outcome from prior exercise within the synapse below research, and is restricted to short-term results that final for at most a couple of minutes.

Forms of synaptic enhancement, equivalent to facilitation, augmentation, and post-tetanic potentiation, are normally attributed to results of a residual elevation in presynaptic [Ca(2+)]i, appearing on a number of molecular targets that seem like distinct from the secretory set off chargeable for quick exocytosis and phasic launch of transmitter to single motion potentials. We talk about the proof for this speculation, and the origins of the totally different kinetic phases of synaptic enhancement, in addition to the interpretation of statistical modifications in transmitter launch and roles performed by different elements equivalent to alterations in presynaptic Ca(2+) inflow or postsynaptic ranges of [Ca(2+)]i. Synaptic melancholy dominates enhancement at many synapses.

Depression is normally attributed to depletion of some pool of readily releasable vesicles, and numerous types of the depletion mannequin are mentioned. Depression may come up from suggestions activation of presynaptic receptors and from postsynaptic processes equivalent to receptor desensitization. In addition, glial-neuronal interactions can contribute to short-term synaptic plasticity. Finally, we summarize the current literature on putative molecular gamers in synaptic plasticity and the consequences of genetic manipulations and different modulatory influences.

Primary construction of the Aequorea victoria green-fluorescent protein.

Many cnidarians make the most of green-fluorescent proteins (GFPs) as energy-transfer acceptors in bioluminescence. GFPs fluoresce in vivo upon receiving vitality from both a luciferase-oxyluciferin excited-state advanced or a Ca(2+)-activated phosphoprotein. These extremely fluorescent proteins are distinctive because of the chemical nature of their chromophore, which is comprised of modified amino acid (aa) residues throughout the polypeptide. This report describes the cloning and sequencing of each cDNA and genomic clones of GFP from the cnidarian, Aequorea victoria.

The gfp10 cDNA encodes a 238-aa-residue polypeptide with a calculated Mr of 26,888. Comparison of A. victoria GFP genomic clones reveals three totally different restriction enzyme patterns which means that at the least three totally different genes are current within the A. victoria inhabitants at Friday Harbor, Washington. The gfp gene encoded by the lambda GFP2 genomic clone is comprised of at the least three exons unfold over 2.6 kb. The nucleotide sequences of the cDNA and the gene will help within the elucidation of structure-function relationships on this distinctive class of proteins.

Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004. Trends within the RO5 literature explosion that may be discerned are the additional definitions of drug-like. This matter is explored when it comes to drug-like physicochemical options, drug-like structural options, a comparability of drug-like and non-drug-like in drug discovery and a dialogue of how drug-like options relate to medical success. Physicochemical options of CNS medicine and options associated to CNS blood-brain transporter affinity are briefly reviewed. Recent literature on options of non-oral medicine is reviewed and the way options of lead-like compounds differ from these of drug-like compounds is mentioned.

Short-term synaptic plasticity.

In vitro molecular mechanisms of bisphenol A motion.

Bisphenol A (BPA, 2,2-bis (4-hydroxyphenyl) propane; CAS# 80-05-7) is a chemical used primarily within the manufacture of polycarbonate plastic, epoxy resins and as a non-polymer additive to different plastics. Recent proof has demonstrated that human and wildlife populations are uncovered to ranges of BPA which trigger adversarial reproductive and developmental results in various totally different wildlife species and laboratory animal fashions. However, there are main uncertainties surrounding the spectrum of BPA’s mechanisms of motion, the tissue-specific impacts of exposures, and the essential home windows of susceptibility throughout which goal tissues are delicate to BPA exposures.

As a basis to handle a few of these uncertainties, this evaluation was ready by the “In vitro” professional sub-panel assembled in the course of the “Bisphenol A: An Examination of the Relevance of Ecological, In vitro and Laboratory Animal Studies for Assessing Risks to Human Health” workshop held in Chapel Hill, NC, Nov 28-29, 2006. The particular cost of this professional panel was to evaluation and assess the energy of the revealed literature pertaining to the mechanisms of BPA motion. The ensuing doc is an in depth evaluation of revealed research which have centered on the mechanistic foundation of BPA motion in various experimental fashions and an evaluation of the energy of the proof relating to the revealed BPA analysis.

In its present state, the database employs an easy-to-use, searchable interface for acquiring detailed information on the 109 at present recognized RNA modifications. Each entry gives the chemical construction, frequent identify and image, elemental composition and mass, CA registry numbers and index identify, phylogenetic supply, sort of RNA species wherein it’s discovered, and references to the primary reported construction willpower and synthesis. Though newly transferred in its entirety to The RNA Institute, the RNAMDB continues to develop with two notable additions, agmatidine and 8-methyladenosine, appended within the final 12 months.

Anti-CD19-ScFv-CD28-CD3ζ (no marker)
LVP1449 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human CD28 stimulatory domain, do not contain any selection marker.

CAR negative control: Anti-CD19-ScFv- CD28 (Puro)
CAR-ctr4 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: Anti-CD19 (CD28) CAR control lentivirus without activation domain, containing Puromycin selection

Anti-CD19-ScFv-4-1BB-CD3ζ (Bsd)
LVP1441 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing Blasticidin selection

Anti-CD19-ScFv-4-1BB-CD3ζ (Puro)
LVP1440 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing Puromycin selection.

Anti-CD19-ScFv-4-1BB-CD3ζ (no marker)
LVP1444 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, do not contain any selection marker.

Anti-CD19-ScFv-4-1BB-CD3ζ (GFP-Puro)
LVP1442 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing GFP-Puromycin dual selection.

Anti-CD19-ScFv-4-1BB-CD3ζ (RFP-Puro)
LVP1443 1x10^8 IFU/ml x 200ul
EUR 455
Description: Anti-CD19 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing RFP-Puromycin dual selection.

CAR negative control: Anti-CD19-ScFv-4-1BB (Puro)
CAR-ctr2 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: Anti-CD19 (4-1BB) control lentivirus without activation domain, containing Puromycin selection

Anti-CD19_CD20-ScFv- CD28-CD3ζ (Puro) Lentivirus
LVP1645 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human CD28 stimulatory domain, containing puromycin antibiotic selection

Anti-CD19_CD20-ScFv- CD28-CD3ζ (No Select) Lentivirus
LVP1644 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human CD28 stimulatory domain, do not contain antibiotic selection

Anti-CD19_CD20-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus
LVP1646 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection

PE anti-CD247 (TCRζ, CD3ζ)
GT19033 100 µg Ask for price

PE anti-CD247 (TCRζ, CD3ζ)
GT19032 25 µg Ask for price

FITC anti-CD247 (TCRζ, CD3ζ)
GT19031 100 µg Ask for price

FITC anti-CD247 (TCRζ, CD3ζ)
GT19030 25 µg Ask for price

Anti-CD19_CD20-ScFv-4-1BB-CD3ζ (Puro) Lentivirus
LVP1642 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing puromycin antibiotic selection

Anti-Human CD28 Recombinant Antibody (Anti-CD28)
YR1618
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

Anti-CD19_CD20-ScFv-4-1BB-CD3ζ (No Select) Lentivirus
LVP1641 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, do not contain antibiotic selection

Anti-CD19_CD20-ScFv-4-1BB-CD3ζ (GFP-Puro) Lentivirus
LVP1643 1x10^8 IFU/ml x 200ul
EUR 553
Description: Bispecific Anti-CD19/CD20 CAR Lentivirus with human 4-1BB (CD137) stimulatory domain, containing GFP-Puromycin dual selection

Anti-CD28 Antibody [CD28.2], PE-25Tests
QAB37-PE-25Tests 25Tests
EUR 169.2

Anti-CD28 Antibody [CD28.2], APC-25Tests
QAB37-APC-25Tests 25Tests
EUR 188.4

Anti-CD28 Antibody [CD28.2], PE-100Tests
QAB37-PE-100Tests 100Tests
EUR 270

Anti-CD28 Antibody [CD28.2], APC-100Tests
QAB37-APC-100Tests 100Tests
EUR 310.8

Anti-CD28 Antibody [CD28.2], FITC-25Tests
QAB37-F-25Tests 25Tests
EUR 157.2

Anti-CD28 Antibody [CD28.2], FITC-100Tests
QAB37-F-100Tests 100Tests
EUR 240

Anti-CD28 Antibody [CD28.2], Qfluor 630-100ug
QAB37-QF630-100ug 100ug
EUR 259.2

Anti-CD28 Antibody [CD28.2], Unconjugated-100ug
QAB37-100ug 100ug
EUR 169.2

Anti-CD28 Antibody [CD28.2], PE-Cy7-25Tests
QAB37-PE7-25Tests 25Tests
EUR 199.2

Anti-CD28 Antibody [CD28.2], PerCP-Cy5.5-100Tests
QAB37-PCP55-100Tests 100Tests
EUR 381.6

Anti-CD28 Antibody [CD28.2], PerCP-Cy5.5-25Tests
QAB37-PCP55-25Tests 25Tests
EUR 229.2

Anti-CD28 Antibody [CD28.2], PE-Cy7-100Tests
QAB37-PE7-100Tests 100Tests
EUR 340.8

Anti-CD3/CD28 stimulus for human PBMC
CT372 50 tests
EUR 141.6

CAR negative control: CD28-CD3ζ (Puro)
CAR-ctr3 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR-T CD28 control lentivirus without targeting domain, containing Puromycin selection

Anti-BCMA-ScFv- CD28-CD3ζ (Puro) Lentivirus
LVP1651 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-BCMA CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-h CD22-ScFv- CD28-CD3ζ (Puro) Lentivirus
LVP1663 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h CD22 CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Hamster Anti CD28 Antibody
20-abx137056
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-h HER2-ScFv- CD28-CD3ζ (Puro) Lentivirus
LVP1657 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HER2 CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-h TGFb-ScFv- CD28-CD3ζ (Puro) Lentivirus
LVP1675 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h TGFb CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-BCMA-ScFv- CD28-CD3ζ (No Select) Lentivirus
LVP1650 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-BCMA CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-BCMA-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus
LVP1652 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-BCMA CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Anti- CD28 Monoclonal Antibody
M00065-1 100ug
EUR 299
Description: Boster Bio Anti- CD28 Monoclonal Antibody catalog # M00065-1. Tested in IHC-P applications. This antibody reacts with Mouse.

Absolute Mcell™ Anti-CD3/CD28 Antibody Magnetic Particles, 5.5 µm, DMF Filed, Sterile
WHM-AB23-095 2.5 mg
EUR 680

Anti-h CD22-ScFv- CD28-CD3ζ (No Select) Lentivirus
LVP1662 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h CD22 CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-CD28
E40YR1618 1 mg
EUR 2960
Description: Available in various conjugation types.

Anti-CD28
MBS156721-01mg 0.1mg
EUR 410

Anti-CD28
MBS156721-1mg 1mg
EUR 1380

Anti-CD28
MBS156721-5x1mg 5x1mg
EUR 5825

anti-CD28
YF-PA10780 50 ug
EUR 435.6
Description: Mouse polyclonal to CD28

Anti-h CD22-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus
LVP1664 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h CD22 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Hamster Anti CD28 FITC Antibody
20-abx137135
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-h HLA-A2-ScFv- CD28-CD3ζ (Puro) Lentivirus
LVP1669 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HLA-A2 CAR Lentivirus with human CD28 stimulatory domain, containing Puromycin antibiotic selection.

Anti-h HER2-ScFv- CD28-CD3ζ (No Select) Lentivirus
LVP1656 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HER2 CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-h TGFb-ScFv- CD28-CD3ζ (No Select) Lentivirus
LVP1674 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h TGFb CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-h HER2-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus
LVP1658 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HER2 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Anti-h TGFb-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus
LVP1676 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h TGFb CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Mouse anti CD28 Monoclonal Antibody
MBS460489-01mg 0.1mg
EUR 320

Mouse anti CD28 Monoclonal Antibody
MBS460489-5x01mg 5x0.1mg
EUR 1390

CAR negative control: CD28-CD3ζ (No Select) Lentivirus
CAR-ctr6 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, does not contain any antibiotic selection

CAR negative control: CD28-CD3ζ (GFP-Puro) Lentivirus
CAR-ctr8 1x10^8 IFU/ml x 200ul
EUR 276.5
Description: CAR (CD28) control lentivirus without targeting domain, containing GFP-Puromycin dual selection

Anti-CD28 [1C6]
MBS488426-02mg 0.2mg
EUR 520

Anti-CD28 [1C6]
MBS488426-5x02mg 5x0.2mg
EUR 2160

Hamster Anti CD28 Biotinylated Antibody
20-abx137134
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Anti-CD28 [D665]
MBS488400-02mg 0.2mg
EUR 520

Anti-CD28 [D665]
MBS488400-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [D665]
MBS488401-02mg 0.2mg
EUR 520

Anti-CD28 [D665]
MBS488401-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [JJ316]
MBS488398-02mg 0.2mg
EUR 520

Anti-CD28 [JJ316]
MBS488398-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [JJ316]
MBS488399-02mg 0.2mg
EUR 520

Anti-CD28 [JJ316]
MBS488399-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 Antibody
A00065 0.1mg
EUR 449
Description: Boster Bio Anti-CD28 Antibody (Catalog # A00065). Tested in ELISA, WB, IHC, IF applications. This antibody reacts with Human.

Anti-CD28 Antibody
E38A8582 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-CD28 Antibody
E38A8787 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-CD28 Antibody
ER2001-42 100ul
EUR 189
Description: CD28 (Cluster of Differentiation 28) is one of the proteins expressed on T cells that provide co-stimulatory signals required for T cell activation and survival. T cell stimulation through CD28 in addition to the T-cell receptor (TCR) can provide a potent signal for the production of various interleukins (IL-6 in particular). CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2) proteins. When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen-presenting cells (APCs). The CD86 expression on antigen-presenting cells is constitutive (expression is independent of environmental factors). CD28 is the only B7 receptor constitutively expressed on naive T cells. Association of the TCR of a naive T cell with MHC:antigen complex without CD28:B7 interaction results in a T cell that is anergic.

Anti-CD28 antibody
STJ16100044 100 µg
EUR 424.8

Anti-CD28 antibody
STJ119563 100 µl
EUR 332.4
Description: The protein encoded by this gene is essential for T-cell proliferation and survival, cytokine production, and T-helper type-2 development. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-CD28 antibody
STJ72503 100 µg
EUR 430.8

Anti-CD28 antibody
STJ96609 200 µl
EUR 236.4
Description: Rabbit polyclonal to CD28.

Anti-h HLA-A2-ScFv- CD28-CD3ζ (No Select) Lentivirus
LVP1668 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HLA-A2 CAR Lentivirus with human CD28 stimulatory domain, does not contain any antibiotic selection.

Anti-h HLA-A2-ScFv- CD28-CD3ζ (GFP-Puro) Lentivirus
LVP1670 1x10^8 IFU/ml x 200ul
EUR 553
Description: Anti-h HLA-A2 CAR Lentivirus with human CD28 stimulatory domain, containing GFP-Puromycin dual selection.

Goat anti-CD28 Antibody
dAP-2339 50ug
EUR 264.6

Goat anti-CD28 Antibody
MBS422554-01mg 0.1mg
EUR 400

Goat anti-CD28 Antibody
MBS422554-5x01mg 5x0.1mg
EUR 1660

Goat Anti-CD28 Antibody
TA311351 100 µg Ask for price

Goat Anti-Cd28 Antibody
TA311383 100 µg Ask for price

Mouse anti-CD28 Antibody
DL99412A-100ul 100 ul
EUR 299
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Mouse anti-CD28 Antibody
DL99412A-50ul 50 ul
EUR 210
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Anti-Cd28 (mouse) antibody
STJ72504 100 µg
EUR 430.8

Anti-CD300f CD300LF Antibody
A07913 100ul
EUR 399
Description: Boster Bio Anti-CD300f CD300LF Antibody catalog # A07913. Tested in IHC, WB applications. This antibody reacts with Human.

Anti-CD163b CD163L1 Antibody
A09845 100ul
EUR 399
Description: Boster Bio Anti-CD163b CD163L1 Antibody catalog # A09845. Tested in IHC, WB applications. This antibody reacts with Human.

Anti-CD109 antigen CD109 Antibody
A03248 100ul
EUR 380
Description: Boster Bio Anti-CD109 antigen CD109 Antibody catalog # A03248. Tested in ELISA, IHC applications. This antibody reacts with Human.

Anti-CD177 antigen CD177 Antibody
A03958 100ul
EUR 399
Description: Boster Bio Anti-CD177 antigen CD177 Antibody catalog # A03958. Tested in IHC, WB applications. This antibody reacts with Human.

Anti-CD160 antigen CD160 Antibody
A06168-2 100ul
EUR 380
Description: Boster Bio Anti-CD160 antigen CD160 Antibody catalog # A06168-2. Tested in ELISA, IHC, WB applications. This antibody reacts with Human.

Anti-CD320 antigen CD320 Antibody
A06409 100ul
EUR 380
Description: Boster Bio Anti-CD320 antigen CD320 Antibody catalog # A06409. Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat.

Anti-CD16/CD32 [2.4G2]
MBS488077-02mg 0.2mg
EUR 520

Anti-CD16/CD32 [2.4G2]
MBS488077-5x02mg 5x0.2mg
EUR 2160

Anti-CD16/CD32 [2.4G2]
MBS488078-02mg 0.2mg
EUR 520

Anti-CD16/CD32 [2.4G2]
MBS488078-5x02mg 5x0.2mg
EUR 2160

Anti-CD30 / TNFRSF8 Antibody (CD30/412)
A1484-100 each
EUR 574.8

Anti-CD28 [15E8], Mouse IgG1
MBS488979-02mg 0.2mg
EUR 520

Anti-CD28 [15E8], Mouse IgG1
MBS488979-5x02mg 5x0.2mg
EUR 2160

Anti-CD28 [15E8], Rabbit IgG
MBS488980-02mg 0.2mg
EUR 520

Anti-CD28 [15E8], Rabbit IgG
MBS488980-5x02mg 5x0.2mg
EUR 2160

Goat anti-Cd28 (mouse) Antibody
dAP-2313 50ug
EUR 264.6

Goat anti-Cd28 (mouse) Antibody
MBS422610-01mg 0.1mg
EUR 400

Goat anti-Cd28 (mouse) Antibody
MBS422610-5x01mg 5x0.1mg
EUR 1660

Anti-CD28 Antibody Picoband™
A00065-3 10ug
EUR 154
Description: Western blot, 0.25-0.5 μg/ml, Human;_x000D_Flow Cytometry, 1-3 μg/1x106 cells, Human;_x000D_Direct ELISA, 0.1-0.5 μg/ml, Human

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal
MBS8101167-01mL 0.1mL
EUR 300

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal
MBS8101167-5x01mL 5x0.1mL
EUR 1200

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal
MBS8101588-01mL 0.1mL
EUR 300

Anti-CD300f/CD300LF Antibody, Rabbit Polyclonal
MBS8101588-5x01mL 5x0.1mL
EUR 1200

Rabbit anti-CD28 (pY218) Antibody
DL90184A-100ul 100 ul
EUR 299
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Rabbit anti-CD28 (pY218) Antibody
DL90184A-50ul 50 ul
EUR 209.3
Description: T-cell-specific surface glycoprotein CD28; TP44; CD28

Rabbit anti-CD28 (pY218) Antibody
YLD1497-100ul 100 ul
EUR 320
Description: Rabbit polyclonal antibody to CD28 (pY218)

Rabbit anti-CD28 (pY218) Antibody
YLD1497-50ul 50 ul
EUR 200
Description: Rabbit polyclonal antibody to CD28 (pY218)

Anti-CD16/CD32 Antibody
E38A8954 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Anti-CD16+CD32 antibody
MO16A(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16A(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16B(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16B(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16CFB(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16CFB(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16F(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16F(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16F(V500) 500 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PE(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PE(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PP(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PP(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PP5.5(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PP5.5(V25) 25 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PU(V100) 100 ug
EUR 60

Anti-CD16+CD32 antibody
MO16PU(V500) 500 ug
EUR 60

Anti-CD28 (pY218) Phospho Antibody
MBS820419-003mL 0.03mL
EUR 195

Anti-CD28 (pY218) Phospho Antibody
MBS820419-01mL 0.1mL
EUR 285

The RNA Modification Database is staying up-to-date with important enhancements being ready for inclusion throughout the subsequent 12 months and the next 12 months. The expanded future position of The RNA Modification Database shall be to function a major info portal for researchers throughout the whole spectrum of RNA-related analysis. Most not too long ago, partly pushed by NIH roadmap initiatives, issues have arisen as to what tool-like means within the seek for chemical instruments to probe biology house.